In the news …
December 2, 2008
Athabasca University: Two Athabasca University Publications Selected for Inclusion in European Science Foundation List
Athabasca University is pleased with the selection of its Journal of Distance Education and The International Review of Research in Open and Distance Learning for inclusion in the European Reference Index for the Humanities (ERIH) initial list.
ERIH is a fully peer-reviewed reference index of the top journals in 15 areas of the Humanities. The two AU publications have been listed in the “Pedagogical and Educational Research” category. Of the five distance journals selected in this category, only the two AU publications are open-access.
"Scholars, researchers and readers are presented with an ever-expanding array of publishing possibilities," said Dr. Terry Anderson, Canada Research Chair in Distance Education. "Many of the traditional citation indices services which track 'influence' of various publications are owned and managed by commercial publishers. I often think they do not index, or adequately review the Open Access journals – their major competitors. Thus, independent peer assessments of journals such as ERIH are important tools for both researchers, those who evaluate research performance and for readers."
Both JDE and IRRODL have become the world's premier academic journals in the field of open and distance education.
Source: Athabasca University, Alberta
November 19, 2008
University of Ottawa Professor Named Canada’s Health Researcher of the Year
At the Canadian Health Research Awards ceremony being held this evening in Ottawa, Dr. Peter Tugwell, Professor in the Departments of Medicine and Epidemiology and Community Medicine at the Institute of Population Health, will be named Canada’s 2008 Health Researcher of the Year – Health Services and Systems and Population Health Research. Dr. Tugwell will be presented with one of the Canadian Institutes of Health Research (CIHR) Michael Smith Prizes in Health Research, a prestigious award that recognizes innovation, creativity and dedication in health research. Named in honour of the late Dr. Michael Smith, who shared the Nobel Prize in chemistry in 1993, the award provides world-class researchers with funding to pursue critical research and to support and mentor trainees.
“It has been my great honour to nominate Dr. Tugwell for this most prestigious of Canadian prizes in health sciences research,” said Dr. Jacques Bradwejn, dean of the Faculty of Medicine at the University of Ottawa. “Peter is being recognized for his global research focused on health equity, his key role in building the discipline of clinical epidemiology and for his mentoring of young researchers worldwide.”
Dr. Tugwell also holds a Canada Research Chair in Health Equity and is a principal scientist at the University of Ottawa’s Institute of Population Health. Further, he is a senior scientist with the Ottawa Health Research Institute. Throughout his career, Dr. Tugwell has worked to bring the world a step closer to achieving health equity through tremendous leadership and outstanding scholarship. After earning his medical degree, Dr. Tugwell and his wife Jane, a nurse, moved to Nigeria, where they lived in a traditional mud house and treated up to 100 patients a day. During this time, Dr. Tugwell also conducted clinical, immunological and epidemiological studies.
Dr. Tugwell brought his passion for medical research to Canada when he took the position of chief resident in internal medicine at McMaster University. In the decades since, he has emerged as one of Canada’s premier healthcare scholars and an international leader in the fight against global health disparities. Since his arrival in Ottawa, he has brought together an incredibly productive team to develop a research program focused on assessing therapeutic interventions, developing strategies for assessing quality of life, improving teaching methods in medicine and contributing to knowledge translation.
Source: University of Ottawa, Ontario
November 19, 2008
University of Manitoba: Major Endowment Strengthens University of Manitoba Leadership in Health Research
Today GlaxoSmithKline Inc. announced a $1 million investment partnership to establish an endowment for a University of Manitoba research chair in the immunobiology of infectious disease.
The University of Manitoba will earmark these funds to establish a research chair in the immunobiology of infectious disease and then recruit a top researcher to hold the chair. The specific research focus will be formalized with the selection of the appropriate candidate.
“The Province of Manitoba is committed to working with its partners; governments and industry, to ensure that an endowed research chair in the immunobiology of infectious disease is established,” said Manitoba Science, Technology, Energy and Mines Minister Jim Rondeau.
The creation of this Chair is part of the GlaxoSmithKline Pathfinders Fund for Leaders in Canadian Health Science Research, a $22 million initiative to encourage health science research and to foster innovation in Canadian medical schools.
“We’ve seen how infectious diseases such as the flu and HIV/AIDS impact people’s lives and we recognize that there is a critical need for continued research in this area,” said Paul Lucas, President and CEO, GlaxoSmithKline Inc. “As a leading developer of specialty care medicines and biologics, we are proud to partner with the University of Manitoba on this important initiative to advance the understanding of infectious diseases and immunobiology.”
“The University of Manitoba is proud to partner with GlaxoSmithKline and Manitoba Science, Technology, Energy and Mines on this significant research initiative,” said David Barnard, President & Vice-Chancellor, University of Manitoba. “This funding will be used to establish a research chair in the immunobiology of infectious disease— an area of significant research strength at the University and in the Province. As one of Canada’s top research-intensive universities, we are pleased about this substantial commitment. It will assist us in leveraging additional investments in an area where our researchers and graduate students are truly making a difference in the local and global community.”
“With the incidence of infectious diseases on the rise, this research chair will enable us to continue to focus our innovation and expertise on leading edge research and education.” said J. Dean Sandham MD, Dean of the Faculty of Medicine at the University of Manitoba. “Partnerships like the Pathfinders Fund for Leaders in Canadian Health Research will help us to attract leading talent to our top research programs in systems biology, immunology, infectious diseases, public health and epidemiology.”
Source: University of Manitoba
November 18, 2008
The University of British Columbia: Premier Opens World-Leading Spinal Cord Injury Centre
The world’s largest, most advanced and most comprehensive facility devoted to spinal cord injury research and patient care was opened today by Premier Gordon Campbell, Rick Hansen and members of the health care and spinal cord research community.
“The Blusson Spinal Cord Centre goes beyond any other facility in the world in bringing spinal cord patients together with outstanding researchers and health-care professionals,” said Premier Campbell. “This fully accessible building will be the most fertile ground anywhere on the planet for the discovery of breakthroughs to help people fully adapt to their injuries. Through this facility, we are providing the tools to improve the lives of thousands of British Columbians and people around the world – and bring us closer to finding a cure for spinal cord injuries.”
The six-storey, $45-million centre is home to ICORD, which stands for International Collaboration on Repair Discoveries and is a partnership of the University of British Columbia, the Rick Hansen Foundation, the Vancouver Coastal Health Research Institute, and the VGH & UBC Hospital Foundation. ICORD has more than 300 researchers working to develop strategies that will help people adapt to and recover from spinal cord injuries.
“Most of what we know about spinal cord injuries has been discovered over the past decade, and the Blusson Spinal Cord Centre will accelerate the pace of those discoveries,” said Ida Chong, Minister of Technology, Trade and Economic Development, who is responsible for research and innovation. “Government’s $12.9-million investment in the centre builds on the $17.25 million we’ve already invested in the past six years to benefit people with spinal cord injuries, and is one of many reasons B.C. is known for world-leading research and innovation.”
The Blusson Spinal Cord Centre is fully accessible, with no need to display the wheelchair disability sign, and integrates research with care. The centre is home to the Brenda and David McLean Integrated Spine Clinic, which provides one-stop outpatient care for people with spinal cord injuries or diseases of the spine. Rick Hansen Foundation programs including the Spinal Cord Injuries Solutions Network and the Rick Hansen Wheels In Motion and Ambassador programs are also located in the centre.
“The realization of this dream will have an extraordinary impact on the community of people living with spinal cord injury across this country today, and those who will be injured in the future,” said Rick Hansen, president and CEO of the Rick Hansen Foundation. “The community of experts, who make up this entire building, will work together to find solutions that improve lives today and move us closer to a cure. I’d particularly like to thank Dr. Stewart and Marilyn Blusson for their contribution, and all the partners who believe in the power of collaboration and partnership to make a difference in the lives of others.”
The Province’s contribution comes from the B.C. Knowledge Development Fund. Other funding was provided by the Canada Foundation for Innovation, the University of B.C. and Vancouver Coastal Health. The Blussons, for whom the facility is named, contributed $8.75 million through the Rick Hansen Foundation.
“Most patients with spinal cord injuries in British Columbia enter the health-care system at VGH, so it is vital that researchers and caregivers have an environment where they can work together to optimize recovery,” said Ida Goodreau, Vancouver Coastal Health’s president and CEO. “This wonderful new centre will influence the care of our patients even before they land on the helipad, and will allow them to return to their communities having experienced a more dramatic recovery than otherwise possible.”
“Interdisciplinary collaboration is one of the exciting features the new Blusson Spinal Cord Centre offers to attract and retain outstanding researchers from around the world,” said UBC president Stephen Toope. “UBC is proud to be a partner in spinal cord injury research. This new world-class centre also provides a unique opportunity to train the next generation of spinal cord researchers.”
The Province has previously contributed $17.25 million to spinal cord injury research and quality of life – $2.25 million to the B.C. Leadership Chair in Spinal Cord Research at the Rick Hansen Institute at UBC and $15 million to the Rick Hansen Foundation in support of its ongoing work to help improve the lives of people with spinal cord injuries.
“The Blusson Spinal Cord Centre project was the catalyst that enabled ICORD to rapidly evolve and expand to be the world’s largest and most comprehensive spinal research centre,” said Dr. John Steeves, founding director of ICORD and holder of the John and Penny Ryan B.C. Leadership Chair in Spinal Cord Research. “Within the past five years, this increased capacity has generated increased knowledge and patents, which have been translated into improved clinical practices and products.”
Almost $345 million has been approved by the Province under the B.C. Knowledge Development Fund since 2001, supporting research at public post-secondary institutions, teaching hospitals and affiliated non-profit agencies. This funding has leveraged $379 million from the Canada Foundation for Innovation and another $283 million from other non-provincial government sources, for a total investment in British Columbia’s research infrastructure of over $1 billion.
“The Blusson Spinal Cord Centr